1.Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013.
Chang Mo OH ; Young Joo WON ; Kyu Won JUNG ; Hyun Joo KONG ; Hyunsoon CHO ; Jong Keun LEE ; Duk Hyoung LEE ; Kang Hyun LEE
Cancer Research and Treatment 2016;48(2):436-450
PURPOSE: This study described the 2013 nationwide cancer statistics in Korea, including cancer incidence, survival, prevalence, and mortality. MATERIALS AND METHODS: Cancer incidence data from 1999-2013 were obtained from Korea National Cancer Incidence Database and followed until December 31, 2014. Mortality data from 1983-2013 were obtained from Statistics Korea. The prevalence was defined as the number of cancer patients alive on January 1, 2014 among all cancer patients diagnosed since 1999. Crude, and age-standardized and 5-year relative survival rates were also calculated. RESULTS: In 2013, a total of 225,343 and 75,334 Koreans were newly diagnosed and died from cancer, respectively. The age-standardized rates for cancer incidence and mortality in 2013 were 290.5 and 87.9 per 100,000, respectively. The age-standardized cancer incidence rate increased 3.1% annually between 1999 and 2013. However, the overall cancer incidence rates have decreased slightly in recent years (2011 to 2013). The age-standardized rate for all-cancer mortality has decreased 2.7% annually since 2002. Overall, the 5-year relative survival rate for people diagnosed with cancer between 2009 and 2013 was 69.4%, which represents an improved survival rate as compared with 41.2% for people diagnosed between 1993 and 1995. CONCLUSION: Age-standardized cancer incidence rates have decreased between 2011 and 2013; mortality rates have also declined since 2002, while 5-year survival rates have improved remarkably from 1993-1995 to 2009-2013 in Korea.
Humans
;
Incidence*
;
Korea*
;
Mortality*
;
Prevalence*
;
Survival Rate
2.Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014.
Kyu Won JUNG ; Young Joo WON ; Chang Mo OH ; Hyun Joo KONG ; Duk Hyoung LEE ; Kang Hyun LEE
Cancer Research and Treatment 2017;49(2):292-305
PURPOSE: This study presents the 2014 nationwide cancer statistics in Korea, including cancer incidence, survival, prevalence, and mortality. MATERIALS AND METHODS: Cancer incidence data from 1999 to 2014 was obtained from the Korea National Cancer Incidence Database and followed until December 31, 2015. Mortality data from 1983 to 2014 were obtained from Statistics Korea. The prevalence was defined as the number of cancer patients alive on January 1, 2015, among all cancer patients diagnosed since 1999. Crude and age-standardized rates (ASRs) for incidence, mortality, prevalence, and 5-year relative survivals were also calculated. RESULTS: In 2014, 217,057 and 76,611 Koreans were newly diagnosed and died from cancer respectively. The ASRs for cancer incidence and mortality in 2014 were 270.7 and 85.1 per 100,000, respectively. The all-cancer incidence rate has increased significantly by 3.4% annually from 1999 to 2012, and started to decrease after 2012 (2012-2014; annual percent change, –6.6%). However, overall cancer mortality has decreased 2.7% annually since 2002. The 5-year relative survival rate for patients diagnosed with cancer between 2010 and 2014 was 70.3%, an improvement from the 41.2% for patients diagnosed between 1993 and 1995. CONCLUSION: Age-standardized cancer incidence rates have decreased since 2012 and mortality rates have also declined since 2002, while 5-year survival rates have improved remarkably from 1993-1995 to 2010-2014 in Korea.
Humans
;
Incidence*
;
Korea*
;
Mortality*
;
Prevalence*
;
Survival Rate
3.Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016
Kyu Won JUNG ; Young Joo WON ; Hyun Joo KONG ; Eun Sook LEE ;
Cancer Research and Treatment 2019;51(2):417-430
PURPOSE: This study presents the 2016 nationwide cancer statistics in Korea, including cancer incidence, survival, prevalence, and mortality. MATERIALS AND METHODS: Cancer incidence data from 1999 to 2016 were obtained from the Korea National Cancer Incidence Database and followed until December 31, 2017. Mortality data from 1983 to 2016 were obtained from Statistics Korea. The prevalence was defined as the number of cancer patients alive on January 1, 2017 among all cancer patients diagnosed since 1999. Crude and age-standardized rates (ASRs) for incidence, mortality, and prevalence and 5-year relative survivals were also calculated. RESULTS: Overall, 229,180 and 78,194 Koreans were newly diagnosed and died from cancer in 2016, respectively. The ASRs for cancer incidence and mortality in 2016 were 269.0 and 79.8 per 100,000 individuals, respectively. The all-cancer incidence rate increased significantly by 3.6% annually from 1999 to 2011 and started to decrease after 2011 (2011-2016; annual percent change, –3.1%). However, overall cancer mortality has decreased 2.7% annually since 2002. The 5-year relative survival rate for patients diagnosed with cancer between 2012 and 2016 was 70.6%, an improvement from the 41.2% for patients diagnosed between 1993 and 1995. CONCLUSION: The cancer prevalence in Korea has increased very fast as survival has improved remarkably. The high prevalence of cancer emphasizes the need for comprehensive cancer control efforts in Korea.
Humans
;
Incidence
;
Korea
;
Mortality
;
Prevalence
;
Survival Rate
4.Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015.
Kyu Won JUNG ; Young Joo WON ; Hyun Joo KONG ; Eun Sook LEE
Cancer Research and Treatment 2018;50(2):303-316
PURPOSE: This study presents the 2015 nationwide cancer statistics in Korea, including the incidence, survival, prevalence, and mortality. MATERIALS AND METHODS: Cancer incidence data from 1999 to 2015 was obtained from the Korea National Cancer Incidence Database and followed until December 31, 2016. Mortality data from 1983 to 2015 were obtained from Statistics Korea. The prevalence was defined as the number of cancer patients alive on January 1, 2016, among all cancer patients diagnosed since 1999. Crude and age-standardized rates (ASRs) for incidence, mortality and prevalence and 5-year relative survivals were also calculated. RESULTS: Herein, 214,701 and 76,855 Koreans were newly diagnosed and died from cancer in 2015, respectively. The ASRs for cancer incidence and mortality in 2015 were 258.9 and 82.0 per 100,000, respectively. The overall cancer incidence rate has increased significantly by 3.4% annually from 1999 to 2012, and started to decrease after 2012 (2012-2015, annual percent change, −6.1%). However, the overall cancer mortality has decreased 2.7% annually since 2002. The 5-year relative survival rate for patients diagnosed with cancer between 2011 and 2015 was 70.7%, an improvement from the 41.2% for patients diagnosed between 1993 and 1995. CONCLUSION: Age-standardized cancer incidence rates have decreased since 2012 and mortality rates have declined since 2002; however, the 5-year survival rates have improved remarkably from 1993-1995 to 2011-2015 in Korea.
Humans
;
Incidence*
;
Korea*
;
Mortality*
;
Prevalence*
;
Survival Rate
5.Studies on bovine besnoitiosis in Korea II. A survey on incidence in the enzootic region.
Hi Suk LEE ; Ung Bok BAK ; Mu Hong MOON ; Jong Uk SHIN
The Korean Journal of Parasitology 1970;8(3):76-80
The 4,725 cattle in the enzootic region, 6 counties of southern Korea, were surveyed for besnoitiosis epidemiologically by examining the scleral conjunctiva for the cysts and the following results were obtained. The survey showed that 285 cattle, representing 6 per cent of a total of 4,725 cattle examined had S.C. cysts. Only 49 (14 per cent) of them showed clinical sclerodermatitis and the ratio between clinical and inapparent cases was 1:5.8. On age distribution of the S.C. positive cases the highest incidence(10-12 per cent) was seen in amimals that were from 5 to 8 years of age, but clinically apparent cases occurred much more in younger age of animal. In local incidence of S.C. cysts positive cases the prevalence was higher in the secluded districts such as Koheung and Sancheoung counties(9 per cent).
parasitology-besnoitiosis
;
epidemiology
;
prevalence rate
;
scleral conjunctiva cyst
6.The prognostic factors and survival analysis of primary peritoneal carcinoma.
Ji Young KWON ; Ji Yoon BAE ; Hyun Jung CHO ; Joo Hyuk CHOI ; Gu Taek HAN ; Joon Mo LEE ; Ki Sung RYU
Korean Journal of Obstetrics and Gynecology 2005;48(12):2896-2902
OBJECTIVE: To date, few attempts have been made at clinical features and prognostic factors of primary peritoneal carcinoma (PPC) because of low prevalence. The aim of this study is to evaluate the clinical characteristcs and determine the prognosis factors of PPC. METHODS: From March 1996 to March 2004, a total of 23 women newly diagnosed with PPC were recruited into the study. Overall survival and prognostic factors were evaluated using Kaplan-Meier method and Cox regression model. RESULTS: The mean age of patients was 58.7+/-7.6 years and the FIGO stage was advanced disease; stage IIIc (73%) and IV (27%). The mean survival time for patients enrolled was 26.0 months. By univariate analysis, tumor state (p=0.028), performance status (p=0.045), the presence of initial debulking operation (p=0.035), and normalization of CA125 at 3 months of treatment (p=0.003) were significantly correlated with survival. On multivariate analysis, only the normalization of CA125 at 3 months of treatment remained as the independent factor for survival (Odds ratio, 6.896; 95% Confidence interval, 1.504-31.623; p=0.013). CONCLUSION: The mean survival time for patients with PPC was 26.0 months, and the normalization of CA125 at 3 months of treatment was identified as the independent prognostic factor. From this study, we analysis the clinical characteristics of PPC and provide more precise understanding of this disease.
Female
;
Humans
;
Multivariate Analysis
;
Prevalence
;
Prognosis
;
Survival Analysis*
;
Survival Rate
7.Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011.
Kyu Won JUNG ; Young Joo WON ; Hyun Joo KONG ; Chang Mo OH ; Duk Hyoung LEE ; Jin Soo LEE
Cancer Research and Treatment 2014;46(2):109-123
PURPOSE: This study aimed to report nationwide cancer statistics in Korea, including incidence, mortality, survival, and prevalence, and their trends. MATERIALS AND METHODS: Incidence data from 1993 to 2011 were obtained from the Korea National Cancer Incidence Database, and vital status was followed through December 31, 2012. Mortality data from 1983 to 2011 were obtained from Statistics Korea. Crude and age-standardized rates for incidence, mortality, and prevalence, and relative survival were calculated. RESULTS: A total of 218,017 cancer cases and 71,579 cancer deaths were reported to have occurred in 2011, and there were 1,097,253 prevalent cases identified in Korea as of January 1, 2012. Over the past 13 years (1999-2011), overall incidence rates have increased by 3.4% per year. The incidence rates of liver and cervical cancers have decreased, while those of thyroid, breast, prostate, and colorectal cancers have increased. Notably, thyroid cancer increased by 23.3% per year in both sexes, and became the most common cancer since 2009. The mortality for all cancers combined decreased by 2.7% per year from 2002 to 2011. Five-year relative survival rates of patients diagnosed in the last 5 years (2007-2011) have improved by 25.1% compared with those from 1993 to 1995. CONCLUSION: Overall cancer mortality rates have declined since 2002 in Korea, while incidence has increased rapidly and survival has improved.
Breast
;
Colorectal Neoplasms
;
Humans
;
Incidence*
;
Korea
;
Liver
;
Mortality*
;
Prevalence*
;
Prostate
;
Survival Rate
;
Thyroid Gland
;
Thyroid Neoplasms
8.Prognostic Significance of Thrombocytosis in Gastric Cancer Patients.
Journal of the Korean Surgical Society 2002;62(4):314-318
PURPOSE: In patients with malignancies, thrombocytosis has been related to the disease stage and survival rate. In this study, special interest was directed to the possible prognostic significance of the platelet counts at diagnosis in patients with gastric cancer. METHODS: Three hundred and sixty-one patients with histologically confirmed gastric cancer who were underwent surgery at the Department of Surgery, Hanyang University Hospital, between January 1994 and December 1998 were reviewed. The relationship between the platelet count (PLT: 10(9)/L), the total WBC count (10(9)/L), the hemoglobin concentration (Hb; g/mL), the serum albumin (g/liter), the disease progression, and the survival rate of the patients were investigated. RESULTS: Thrombocytosis (PLT greater than 400) was present in 29 patients (8.0%) and anemia (Hb less than 12) was present in 130 patients (36.0%). The mean value of the PLT count increased significantly according to the advancement of the disease stage (stage I; 242, stage II; 258, stage III; 277, stage IV; 288, P value=0.000). The hemoglobin concentrations were negatively correlated with the platelet counts (gamma=-0.257, P=0.000). The prevalence of thrombocytosis was 3.0% and 8.3% in patients with stages I and II, respectively, which increased to 10.8% and 12.9% in patients with stages III and IV, respectively. These differences in the prevalence of thrombocytosis reached statistical significance (P=0.022). The five-year survival rate in patients with or without thrombocytosis was significantly different (42.6%, 65.9%, respectively; P=0.0123) CONCLUSION: Because patients with thrombocytosis have correlation with advancing stage and a poor prognosis, the platelet count at diagnosis may give additional prognostic information for patients with gastric cancer. Elevated platelet counts are mainly associated with the presence of anemia.
Anemia
;
Diagnosis
;
Disease Progression
;
Humans
;
Platelet Count
;
Prevalence
;
Prognosis
;
Serum Albumin
;
Stomach Neoplasms*
;
Survival Rate
;
Thrombocytosis*
9.Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010.
Kyu Won JUNG ; Young Joo WON ; Hyun Joo KONG ; Chang Mo OH ; Hong Gwan SEO ; Jin Soo LEE
Cancer Research and Treatment 2013;45(1):1-14
PURPOSE: This article gives an overview of nationwide cancer statistics, including incidence, mortality, survival and prevalence, and their trends in Korea based on 2010 cancer incidence data. MATERIALS AND METHODS: Incidence data from 1993 to 2010 were obtained from the Korea National Cancer Incidence Database, and vital status was followed until 31 December 2011. Mortality data from 1983 to 2010 were obtained from Statistics Korea. Crude and age-standardized rates for incidence, mortality, prevalence, and relative survival were calculated. RESULTS: In total, 202,053 cancer cases and 72,046 cancer deaths occurred during 2010, and 960,654 prevalent cancer cases were identified in Korea as of 1 January 2011. The incidence of all cancers combined showed an annual increase of 3.3% from 1999 to 2010. The incidences of liver and cervical cancers have decreased while those of thyroid, breast, prostate and colorectal cancers have increased. Notably, thyroid cancer, which is the most common cancer in Korea, increased by 24.2% per year rapidly in both sexes. The mortality of all cancers combined showed a decrease by 2.7% annually from 2002 to 2010. Five-year relative survival rates of patients who were diagnosed with cancer from 2006 to 2011 had improved by 22.9% compared with those from 1993 to 1995. CONCLUSION: While the overall cancer incidence in Korea has increased rapidly, age-standardized cancer mortality rates have declined since 2002 and survival has improved.
Breast
;
Colorectal Neoplasms
;
Humans
;
Incidence
;
Korea
;
Liver
;
Prevalence
;
Prostate
;
Survival Rate
;
Thyroid Gland
;
Thyroid Neoplasms
10.Chronic kidney disease in Korea.
Korean Journal of Medicine 2009;76(5):511-514
Chronic kidney disease (CKD) is an important problem worldwide. CKD is defined as either a glomerular filtration rate (GFR) of less than 60 mL/min/1.73 m2 body surface area (BSA) or the presence of kidney damage, most commonly assessed by the presence of albuminuria for at least three consecutive months. In Korea, the reported overall prevalence of CKD is 13.7%, and the prevalence of CKD according to stage is 2.0, 6.7, 4.8, 0.2, and 0.0% for stages 1 to 5, respectively. This review emphasizes the importance of awareness, making an early diagnosis, and an appropriate management strategy for CKD.
Albuminuria
;
Body Surface Area
;
Early Diagnosis
;
Glomerular Filtration Rate
;
Kidney
;
Korea
;
Prevalence
;
Renal Insufficiency, Chronic